Celularity
CELU
45 hedge funds and large institutions have $8.02M invested in Celularity in 2023 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 13 increasing their positions, 8 reducing their positions, and 16 closing their positions.
7,100% more call options, than puts
Call options by funds: $72K | Put options by funds: $1K
63% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 8
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0.06% less ownership
Funds ownership: 1.96% → 1.9% (-0.06%)
20% less funds holding
Funds holding: 56 → 45 (-11)
57% less capital invested
Capital invested by funds: $18.8M → $8.02M (-$10.7M)
69% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 16
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$319K |
| 2 |
Millennium Management
New York
|
+$97.6K |
| 3 |
Renaissance Technologies
New York
|
+$96.6K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$36.3K |
| 5 |
IIA
IPG Investment Advisors
San Diego,
California
|
+$30.5K |
Top Sellers
| 1 |
YIH
Y-Intercept (HK)
Hong Kong
|
-$78.9K |
| 2 |
HF
HRT Financial
New York
|
-$74K |
| 3 |
Goldman Sachs
New York
|
-$72.6K |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$49K |
| 5 |
OMC
Old Mission Capital
Chicago,
Illinois
|
-$34.9K |
CELU Hedge Fund Activity: Q3 2023 in Review
45 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Celularity (CELU) for Q3 2023, worth a combined $8.02M — down 57% from $18.8M a quarter earlier.
Sellers outnumbered buyers: 16 funds closed out of CELU and 5 opened new positions — a net loss of 11 holders — while 8 trimmed existing stakes and 13 added.
The largest buyer was Vanguard Group, adding an estimated $319K. The largest seller was Y-Intercept (HK), exiting entirely with an estimated $78.9K sold.
- 45 institutional investors held Celularity (CELU) as of Q3 2023, down from 56 in Q2 2023.
- Funds reported $8.02M of Celularity stock for Q3 2023, down 57% quarter-over-quarter.
- 5 funds opened new Celularity positions in Q3 2023 and 16 closed out, a net change of -11 holders.
- The largest Celularity buyer in Q3 2023 was Vanguard Group, an estimated $319K added.
- The largest Celularity seller in Q3 2023 was Y-Intercept (HK), an estimated $78.9K sold.
Based on aggregated 13F filings for Q3 2023.